Joel Wight

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

Maher K. Gandhi, Thanh Hoang, Soi Cheng Law et al. · Blood · 2020 · 119 citations · Full text

Medicine, Immunology, Oncology +12

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the <scp>COVID</scp>‐19 pandemic

Pietro R Di Ciaccio, Georgia McCaughan, Judith Trotman et al. · Internal Medicine Journal · 2020 · 43 citations · Full text

Medicine, Infectious Diseases, Oncology +15

Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B‐cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance

Joel Wight, Mimi Yue, Colm Keane et al. · British Journal of Haematology · 2019 · 35 citations · Full text

Medicine, Oncology, Chemotherapy +12

Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes

Piers Blombery, Lucy C. Fox, Georgina L. Ryland et al. · Haematologica · 2020 · 29 citations · Full text

Life Sciences, Genetics, Hematology +17

Dapsone safety in hematology patients: Pathways to optimizing <i>Pneumocystis jirovecii</i> pneumonia prophylaxis in hematology malignancy and transplant recipients

Karen Urbancic, Daisy Pisasale, Joel Wight et al. · Transplant Infectious Disease · 2018 · 15 citations

Pharmacy, Hematology, Pharmacology +14